In a report released today, Serge Belanger from Needham maintained a Buy rating on Verrica Pharmaceuticals (VRCA), with a price target of $22.00.
The post Needham Sticks to Its Buy Rating for Verrica Pharmaceuticals (VRCA) appeared first on Smarter Analyst.
In a report released today, Serge Belanger...

https://www.smarteranalyst.com/new-blurbs/needham-sticks-to-its-buy-rating-for-verrica-pharmaceuticals-vrca/

#SmarterAnalyst